RESI Certificate 1st Prize (Concarlo Holdings)

RESI Innovator’s Pitch Challenge Winner

Concarlo wins the Innovator’s Pitch Challenge at RESI Jan 2021!

Targeting p27Kip1 to Treat Drug-Resistance Cancer

Stacy Blain, PhD, Founder, CSO and CEO

US biotech start-up set to have huge impact on breast cancer treatment landscape

Click to read the Drug Discovery World article about Concarlo, also featured in their fall issue.

Concarlo: targeting proliferation and resistance in one go

Click to read the BioCentury Emerging Company Profile.

TigerTalks in the City: How Genomics Are Driving Novel Therapies

Stacy was a panelist at Princeton Entrepreneurship Council’s popular panel discussion series. Click to learn more.

2019 Social Enterprise Conference

Stacy Blain was a panelist at Columbia University’s Social Enterprise Conference.

WE NYC Women in Tech Conference

Stacy Blain was a panelist at WE NYC’s annual summit, Female Founders Disrupting HealthTech, at the New York Genome Center.

NYU Female Founders Forum

Stacy presenting on April 12, 2019.

Impact Journals: March 2019

Click here to download the manuscript: Tyrosine Phosphorylation of p27Kip1 Correlates with Palbociclib Responsiveness in Breast Cancer Tumor Cells Grown in Explant Culture

Proactive Investors Interview

At the 11th Annual Biotech Showcase in San Francisco

Women & Wealth Magazine: 18 Women to Watch in 2018

Features Dr. Stacy Blain, Co-Founder and Chief Scientific Officer, Concarlo Holdings

SUNY Downstate Medical Center Press Release

SUNY Downstate Startup Company Secures Over $1 Million in Seed Funding Investment for Advancement of Proprietary Cancer Companion Diagnostic Test

Newsday Business Article

LI venture capital fund invests in NYC biotech startup

Impact Journals: Oncoscience May 2018

Click here to download Stacy’s article: Targeting p27 tyrosine phosphorylation as a modality to inhibit CDK4 and CDK2 and cause cell cycle arrest in breast cancer cells.

Molecular Cancer Research Journal: March 2018

Click here to download Stacy and Priyank’s article:
Dual Inhibition of CDK4 and CDK2 via Targeting p27 Tyrosine Phosphorylation Induces a Potent and Durable Response in Breast Cancer Cells

Going Through It Together

Stacy and Catherine’s Grand Canyon Hike

Student Visit from Edsnaps

Increasing diversity in the science technology engineering & mathematics (STEM) workforce.

Research Associate Sarah Teed, M.S. welcomes young students to learn more about Concarlo’s mission.